Regenxbio Inc (RGNX)
11.48
+0.10
(+0.88%)
USD |
NASDAQ |
Sep 06, 16:00
11.48
0.00 (0.00%)
After-Hours: 20:00
Regenxbio Price to Book Value: 1.629 for Sept. 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 06, 2024 | 1.629 |
| September 05, 2024 | 1.615 |
| September 04, 2024 | 1.601 |
| September 03, 2024 | 1.609 |
| August 30, 2024 | 1.734 |
| August 29, 2024 | 1.703 |
| August 28, 2024 | 1.669 |
| August 27, 2024 | 1.648 |
| August 26, 2024 | 1.719 |
| August 23, 2024 | 1.721 |
| August 22, 2024 | 1.655 |
| August 21, 2024 | 1.733 |
| August 20, 2024 | 1.684 |
| August 19, 2024 | 1.771 |
| August 16, 2024 | 1.738 |
| August 15, 2024 | 1.761 |
| August 14, 2024 | 1.693 |
| August 13, 2024 | 1.747 |
| August 12, 2024 | 1.696 |
| August 09, 2024 | 1.658 |
| August 08, 2024 | 1.687 |
| August 07, 2024 | 1.709 |
| August 06, 2024 | 1.801 |
| August 05, 2024 | 1.775 |
| August 02, 2024 | 1.850 |
| Date | Value |
|---|---|
| August 01, 2024 | 1.889 |
| July 31, 2024 | 2.022 |
| July 30, 2024 | 2.028 |
| July 29, 2024 | 2.036 |
| July 26, 2024 | 2.034 |
| July 25, 2024 | 2.042 |
| July 24, 2024 | 1.932 |
| July 23, 2024 | 1.912 |
| July 22, 2024 | 1.808 |
| July 19, 2024 | 1.781 |
| July 18, 2024 | 1.820 |
| July 17, 2024 | 1.880 |
| July 16, 2024 | 1.920 |
| July 15, 2024 | 1.822 |
| July 12, 2024 | 1.808 |
| July 11, 2024 | 1.800 |
| July 10, 2024 | 1.521 |
| July 09, 2024 | 1.500 |
| July 08, 2024 | 1.505 |
| July 05, 2024 | 1.544 |
| July 03, 2024 | 1.532 |
| July 02, 2024 | 1.522 |
| July 01, 2024 | 1.568 |
| June 30, 2024 | |
| June 28, 2024 | 1.475 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.210
Minimum
May 24 2022
5.603
Maximum
Jan 14 2021
2.544
Average
2.383
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 11.42 |
| Pfizer Inc | 1.845 |
| Catalyst Pharmaceuticals Inc | 3.820 |
| Vertex Pharmaceuticals Inc | 8.175 |
| Edgewise Therapeutics Inc | 3.224 |
Price to Book Value Related Metrics
| PS Ratio | 5.940 |
| Price | 11.48 |
| Earnings Yield | -45.82% |
| Market Cap | 567.38M |